| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2726595 | Seminars in Radiation Oncology | 2015 | 8 Pages |
Abstract
The use of radiotherapy in low-grade glioma has been a topic of controversy over the past 2 decades. Although earlier studies showed no overall survival benefit and no dose response, recent studies demonstrate a possible synergism between radiotherapy and chemotherapy. However, many questions remained unanswered regarding the proper management including the potential roles of biological imaging in treatment planning, the role of reirradiation after recurrence, the role of intensity-modulated radiation therapy and proton beam radiotherapy, and the proper choice of chemotherapy agents. Further clinical trials are necessary to help integrate these new therapies and technologies into clinical practice.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Michael D. Chan,